Concepedia

Marcel Meury

MM

Statistics

Publications

24

Citations

3.2K

H-Index

21

Active since

2009

Affiliations

VIR Biotechnology (United States)(Current)

Vir Biotechnology (Switzerland)

Washington University in St. Louis

University of Basel

University of Bern

Marcel Meury is an author at VIR Biotechnology (United States) specializing in life sciences, biochemistry, and structural biology.

ORCID

Publications per year

2009–2023

24

Publications

24

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson, Laura E. Rosen, James G. Shepherd et al. · Cell · 2021 · 657 citations · Full text

, , +15

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp et al. · Science · 2020 · 627 citations · Full text

, , +17

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Tyler N. Starr, Nadine Czudnochowski, Zhuoming Liu et al. · Nature · 2021 · 590 citations · Full text

, , +16

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

Florian A. Lempp, Leah Soriaga, Martin Montiel-Ruiz et al. · Nature · 2021 · 326 citations · Full text

, , +14

The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity

Emma C. Thomson, Laura E. Rosen, James G. Shepherd et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 118 citations · Full text

, , +15

1–5 of 24